Cadila Healthcare has informed that the company enclosed a Press Release dated May 2, 2020 titled ‘Zydus receives tentative approval from the USFDA for Empagliflozin and Metformin Hydrochloride Tablets’.
The above information is a part of company’s filings submitted to BSE.